Metraipolis › archive › dc_4e63f8b0fb05
Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome — Europe PMC PMID:39235366
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39235366
- DOI
- 10.1128/msystems.00788-24
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:24:21.277Z
- SHA-256 of the archived text
c6ee94d9d8ecdcbc65ccb811767647eb9a80df3d9709a6c58f83e399b10e95b5- Stable URL of this page
https://metraipolis.com/documento/dc_4e63f8b0fb05
How to cite
Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome — Europe PMC PMID:39235366 — Europe PMC (en), https://europepmc.org/article/MED/39235366 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e63f8b0fb05 (Metraipolis archive dc_4e63f8b0fb05, sha256 c6ee94d9d8ecdcbc65ccb811767647eb9a80df3d9709a6c58f83e399b10e95b5)
BibTeX
@misc{dc4e63f8b0fb05,
title = {Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome — Europe PMC PMID:39235366},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39235366},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e63f8b0fb05; sha256 c6ee94d9d8ecdcbc65ccb811767647eb9a80df3d9709a6c58f83e399b10e95b5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39235366. Agents can read the archived copy with the MCP tool read_document.